These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6301522)

  • 81. Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus.
    Roos RP; Richards OC; Green J; Ehrenfeld E
    J Virol; 1982 Sep; 43(3):1118-22. PubMed ID: 6292455
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses.
    Nitayaphan S; Toth MM; Roos RP
    J Virol; 1985 Feb; 53(2):651-7. PubMed ID: 2578578
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region.
    Rodriguez M; Leibowitz J; David CS
    J Exp Med; 1986 Mar; 163(3):620-31. PubMed ID: 3005466
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses.
    Rodriguez M; Roos RP
    J Virol; 1992 Jan; 66(1):217-25. PubMed ID: 1727485
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Distribution of Theiler's virus in the CNS of athymic nude mice: effect of varying the route of inoculation.
    Love S
    J Neurol Sci; 1987 Oct; 81(1):55-66. PubMed ID: 2824701
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype.
    Roos RP; Stein S; Routbort M; Senkowski A; Bodwell T; Wollmann R
    J Virol; 1989 Oct; 63(10):4469-73. PubMed ID: 2476574
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Remyelination during remission in Theiler's virus infection.
    Dal Canto MC; Barbano RL
    Am J Pathol; 1984 Jul; 116(1):30-45. PubMed ID: 6742106
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system.
    Rozhon EJ; Kratochvil JD; Lipton HL
    Virology; 1983 Jul; 128(1):16-32. PubMed ID: 6192587
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses.
    Lipton HL
    Infect Immun; 1978 Jun; 20(3):869-72. PubMed ID: 208981
    [TBL] [Abstract][Full Text] [Related]  

  • 90. In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection.
    Ozden S; Aubert C; Gonzalez-Dunia D; Brahic M
    J Histochem Cytochem; 1991 Oct; 39(10):1305-9. PubMed ID: 1940303
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Theiler's virus-induced demyelination: prevention by immunosuppression.
    Lipton HL; Dal Canto MC
    Science; 1976 Apr; 192(4234):62-4. PubMed ID: 176726
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection.
    Zurbriggen A; Thomas C; Yamada M; Roos RP; Fujinami RS
    J Virol; 1991 Apr; 65(4):1929-37. PubMed ID: 1705992
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Theiler's virus encephalomyelitis is unaffected by treatment with myelin components.
    Lang W; Wiley C; Lampert P
    J Neuroimmunol; 1985 Jul; 9(1-2):109-13. PubMed ID: 4008634
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease.
    Rodriguez M; Lindsley MD
    Neurology; 1992 Feb; 42(2):348-57. PubMed ID: 1736164
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses.
    Nitayaphan S; Omilianowski D; Toth MM; Parks GD; Rueckert RR; Palmenberg AC; Roos RP
    Intervirology; 1986; 26(3):140-8. PubMed ID: 3034822
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Pathogenesis of Theiler's murine encephalomyelitis virus.
    Yamada M; Zurbriggen A; Fujinami RS
    Adv Virus Res; 1991; 39():291-320. PubMed ID: 2038955
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts.
    McAllister A; Tangy F; Aubert C; Brahic M
    Microb Pathog; 1989 Nov; 7(5):381-8. PubMed ID: 2560113
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Uncoupled relationship between demyelination and primary infection of myelinating cells in Theiler's virus encephalomyelitis.
    Dal Canto MC
    Infect Immun; 1982 Mar; 35(3):1133-8. PubMed ID: 6279514
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease.
    Aubert C; Chamorro M; Brahic M
    Microb Pathog; 1987 Nov; 3(5):319-26. PubMed ID: 2849023
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Analysis of proteolipid protein and P0 transcripts in mice infected with Theiler's virus.
    Ozden S; Aubert C; Bureau JF; Gonzalez-Dunia D; Brahic M
    Microb Pathog; 1993 Feb; 14(2):123-31. PubMed ID: 7684806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.